Clinical Trials Browser

Phase EARLY_PHASE1 × Recruiting × Leukemia × Clear all

Leukemia

NCT07429461 2026-02-24

Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia

Phase EARLY_PHASE1 Recruiting

16 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia

NCT02356653 2026-02-20

ExpMACs

Phase EARLY_PHASE1 Recruiting

100 enrolled

Other hematologic neoplasm

Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome, Bone Marrow Failure Disorders, Immunologic Deficiency Syndromes, Leukemia, Metabolism, Inborn Errors

NCT06756321 2025-01-03

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

Phase EARLY_PHASE1 Recruiting

9 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

NCT06643221 2024-10-16

Allo-X

Phase EARLY_PHASE1 Recruiting

100 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Motor Activity

Clinical Trials

Clinical Study on the Safety and Efficacy of BiTE-EV in Relapsed/Refractory Acute B-Cell Leukemia

Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia

ExpMACs

A Study of CAR T-Cells in Relapsed/Refractory Hematologic Malignancy

Allo-X